Medical Oncologist. Breast & Gynae tumors at HRU-HVV Málaga 👩🏼⚕️👩🏼🏫🦀🥊 “Why do we fall Bruce? So that we can learn to pick ourselves up"Joined October 2023
Not just coffee - even pembrolizumab works better before 11 AM ☕💉
📊 Eur J Cancer 2025 | 9-center retrospective | n=450
1L Pembrolizumab monotherapy in advanced NSCLC
Timing groups:
🌅 Early ≤11:00 AM
🌙 Late >11:00 AM
Results (PSM, n=206 | median f/u 62.5 mo):
•OS: 43.7…
🆕@ASCO Global Guideline: Geriatric Assessment (GA) for adults 65+ w cancer
✅GA identifies vulnerabilities not seen in routine oncology visits
✅GA-guided management should inform all care plans
✅Tools like the PGA are validated🌐
@EnriqueSoto8ascopubs.org/doi/pdf/10.120…
T-DXd Retreatment After ILD (Pooled analysis – 9 trials, 2145 pts)
🔹️23% of pts with G1 ILD were retreated
🔹️ILD recurrence in 33% (all G1–2, no G5)
🔹️20% discontinued due to ILD2
🔹️75% of steroid-treated pts recovered
💥 Retreatment appears feasible with proper…
Now out in @TheLancet the results of the randomized trial ASTER 70s
The addition of adjuvant CT to HT had no significant survival benefit in women aged >=70 years with a GGI high-risk ER+ HER2-neg early BC, and had more toxicity
👵🏻🛑
@OncoAlertthelancet.com/journals/lance…
🧵POSITIVE trial changes how we counsel young HR+ Breast cancer pts
✅74% conceived after pausing endocrine therapy, 65% even with AMH <0.5 ng/mL
🤰Low ovarian reserve ≠ No chance.
📉 LOR was the strongest predictor of reduced fertility
1/3
thebreastonline.com/article/S0960-…@OncoAlert
PALMARES-2 study @Annals_Oncology
Real-world effectiveness of first-line palbociclib, ribociclib or abemaciclib plus ET in HR+/HER2- mBC
Different effectiveness of the three CDK4/6i observed in different clinical settings
annalsofoncology.org/article/S0923-…@OncoAlert
In a silent trial involving 197 lung cancer patients over the span of four months, a pathology foundation model was able to identify presence of EGFR mutations with high accuracy, potentially preventing further genetic testing in 43% of cases.
nature.com/articles/s4159…
Fascinating paper in @Cancer_Cell by @CharlesSwanton => direct functional evidence for cancer cell-intrinsic subclonal immune evasion in 3 different settings in lung cancer: different subclones = different responses to immune pressure
Avutometinib and defactinib in low grade ovarian cancer - FDA accelerated approval for KRAS altered tumors and ongoing RAMP 301 will answer efficacy question for KRASwt. This is the first approval in LGS and the first big advance for our patients. Understanding toxicity…
🕐 OS according to time-of-day of combined IO-Ct: a bicentric bicontinental study.
In advanced NSCLC, patients receiving immuno-chemotherapy before 11:30 a.m. had longer overall survival (33 vs 19.5 months).
Real-world data from France & China point to a potential role for…
Primary tumour resection plus systemic therapy versus systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC): a randomised clinical trial
buff.ly/Fmhuyub
In a randomized study of 407 patients with de novo stage IV #BreastCancer , primary tumor…
💪🏻 Ejercicio: la medicina que tu cuerpo reconoce al instante
4 estudios clave revelan cómo el ejercicio no solo previene, sino modifica procesos moleculares en tu cuerpo:
🧠 Mejora la memoria (cathepsina B)
🦴 Regula el metabolismo (osteocalcina-IL6)
🦠 Disminuye tumores (células…
1K Followers 7K FollowingStoic | Molecular Oncology | Medical Oncology | Manchester United | Metallica | CR7 | Schumacher | Federer | Bryant | Views are my own
284 Followers 354 FollowingMother, Person and Gynecologist (the order of the factors does not alter the product). Working for Novartis Medical department. Personal opinions
4K Followers 956 FollowingIn love with Immunoinfectology, Medical & Public Health Microbiology, Infectious Diseases Pathology & Vaccinology. Passionate History of Infectious Diseases .
21K Followers 15K FollowingSomos el Hospital Universitario La Luz de Madrid (antes Clínica La Luz), integrado en @quironsalud. Para nosotros el paciente siempre es lo primero.
1K Followers 872 FollowingMedical Oncologist / 🏥Research Staff at MGH, Boston/ Joan Rodés researcher 👩🏻🔬/ Research on CRC 🧬/Liquid Biopsy🩸/🏠Barrio La Torre💔#Dana
946 Followers 4K FollowingKOL Pulse AI is a Healthcare Intelligence Application focused on the Social Conversations and Digital Signature of Key Opinion Leaders in Medicine.
40K Followers 25K Following📢 Ven a lo fácil y contrata un seguro de salud que se adapta a ti
📞 976 50 60 00
📲 960 16 06 02
🕰 L-V de 8h a 21
✉️ [email protected]
88K Followers 95K FollowingAuthor of the coming book: "The Managed Care Blues: A Doctor's Journey, a Broken System, Real Solutions." Retired physician. Patient and doctor advocate.
16K Followers 8K FollowingPerfil del Hospital Universitario @quironsalud Madrid, referencia de la sanidad privada española por la excelencia de sus profesionales y su tecnología médica.
58K Followers 36K FollowingCanal de divulgación médica con rigor científico de Quirónsalud, grupo de salud líder en España. Atendemos tus dudas y preguntas en @Quironsalud_PAC
4K Followers 1K FollowingSince 1965. Observer. Medical Oncologist. Spanish Group for Breast Cancer Research (GEICAM). Álvaro Rodríguez-Lescure MD, PhD.
566 Followers 477 FollowingMedical Oncologist. Breast Cancer. 🏥 Ramón y Cajal University Hospital (Madrid) IOB MADRID Hospital Beata María Ana (Madrid)
927 Followers 515 FollowingJuan M. Cejalvo, MD PhD. Medical Oncologist. Biomedical Research Institute INCLIVA. Hospital Clínico Universitario of Valencia. Board Member of @_SOLTI #BeSOLTI
2.6M Followers 3K FollowingResearch, News, and Commentary from Nature, the international science journal
For daily science news, get Nature Briefing: https://t.co/wGmQlQ8a4D
352K Followers 253 FollowingNature Medicine is a research journal devoted to publishing the latest advances in translational and clinical research for scientists and physicians.
15K Followers 310 FollowingImpactful information & insights to changes & challenges inherent in delivering equitable, high-quality oncology care. Part of @JCO_ASCO family of journals.
8K Followers 138 FollowingOncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists
2K Followers 54 FollowingThe Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research; Deputy Director of Clinical Sciences at @UNC_Lineberger
284 Followers 354 FollowingMother, Person and Gynecologist (the order of the factors does not alter the product). Working for Novartis Medical department. Personal opinions
2K Followers 24 FollowingDirector of the UT Southwestern Simmons Cancer Center, @UTSWcancer. Cancer investigator, breast medical oncologist, father of 4. Views are my own.
1K Followers 872 FollowingMedical Oncologist / 🏥Research Staff at MGH, Boston/ Joan Rodés researcher 👩🏻🔬/ Research on CRC 🧬/Liquid Biopsy🩸/🏠Barrio La Torre💔#Dana
3K Followers 493 FollowingLa mutualidad de los médicos. Entidad colaborativa. Reinvertimos todos los beneficios en el colectivo médico. Somos la #AlternativaReta 💙 T. 900 82 88 99
926 Followers 857 FollowingPresidesidenta de ALMIA.España.🇪🇦
Presidenta y cofundadora Asociación Española de Cáncer de Mama Metastásico desde Febrero de 2018 hasta diciembre de 2024
566 Followers 477 FollowingMedical Oncologist. Breast Cancer. 🏥 Ramón y Cajal University Hospital (Madrid) IOB MADRID Hospital Beata María Ana (Madrid)
4K Followers 2K FollowingMD, Medical Oncologist🇮🇹•Research Physician at @JulesBordet Institute in Brussels🇧🇪 Great interest in #BreastCancer and #ImmunoOncology
355 Followers 674 FollowingOncologa, llena de preguntas. Y ademas de la medicina muchas otras inquietudes #breastcancer #cancerdemama #oncologia #mendia #GEICAM #BIOGIPUZKOA
2K Followers 3K FollowingEl sindicato de #médicos, #odontólogos, #veterinarios, #biólogos, #farmacéuticos, #bioquímicos, #psicólogos, #radiofísicos y del sector de #Salud en #Málaga